Products from UK-based CBD brand Trip have been restocked at health food retailer Holland & Barrett after being withdrawn last week due to updated Food Standards Agency (FSA) guidelines .
The UK FSA has reduced its recommended daily CBD consumption limit from 70 mg to 10 mg. It states that high CBD consumption over a lifetime could increase the risk of liver damage, drowsiness (excessive fatigue), and thyroid problems.
This caused concern among some retailers and Holland & Barrett responded by temporarily removing Trips products from shelves.
A Holland & Barrett spokesperson said: As a responsible retailer, we always act in the best interests of our customers. That’s why we temporarily removed certain products from sale while our scientific, legal and independent advisors evaluated the new FSA guidelines.
In line with FSA guidance, we have now developed advice, colleague training, online advice and on-shelf information, meaning customers can access the information they need when choosing dosage that suits them.
Travel confirmed to Just drinks that Holland & Barrett was the only store to temporarily remove its listings, which totaled 31 products.
Access the most comprehensive company profiles on the market, powered by GlobalData. Save hours of research. Gain a competitive advantage.
Free Company Profile Sample
THANKS!
Your download email will arrive shortly
We are confident in the unique quality of our business profiles. However, we want you to make the decision that is best for your business, which is why we are offering a free sample that you can download by submitting the form below.
By GlobalData
A Trip spokesperson said: Not all CBD is created equal. The FSA’s recommended daily guideline for the 10 mg dose of CBD is based on a study of three samples of lower-quality ingredients, which do not include Trips CBD.
They added: This message is echoed by Trips’ retail partners, who have provided overwhelming support. Retailers are clear that Trip is fully compliant with the regulations.
The UK-based CBD brand was created in 2018 by Olivia Ferdi and her husband Dan Khoury after suffering a knee accident requiring surgery. The duo discovered CBD during their healing process.
A privately held company, Trip does not provide publicly available sales and profit figures, but claims to have an 88% share of the CBD beverage market in Europe. Its products are stocked in 25,000 points of sale in Europe, including Sainsburys, Boots and Harrods in the UK.
The Association for the Cannabinoid Industry (ACI), a London-based organisation, said the FSA guidelines would not have an immediate impact on the UK’s list of permitted CBD products.
In a statement following the FSA update, the ACI said: We urge retailers to take this as a guide, which it is. Nothing will change immediately in terms of products on the FSA public list.
CBD is a chemical compound found in the cannabis plant that has little to no psychoactive properties of tetrahydrocannabinol (THC), the compound in cannabis that causes a high when consumed.
Emily Miles, CEO of the FSA, said at the time: “We understand that this change in our advice will have implications for products currently on the market that contain more than 10 mg of CBD per serving. We will work closely with industry to minimize the risk of consumers being exposed to potentially harmful levels of CBD.
#Trips #CBD #products #shelves #retailer #scare #updated #FSA #guidelines
Image Source : www.just-drinks.com